Discovery of DS34942424: An orally potent analgesic without mu opioid receptor agonist activity.

Bioorg Med Chem

Medicinal Chemistry Research Laboratories, R&D Division, Daiichi Sankyo Co., Ltd., 1-2-58 Hiromachi, Shinagawa-ku, Tokyo 140-8710, Japan.

Published: November 2020

We identified (5'S)-10'-fluoro-6'-methyl-5',6'-dihydro-3'H-spiro[cyclopropane-1,4'-[2,6]diaza[2,5]methano[2,6]benzodiazonin]-7'(1'H)-one, 22b (DS34942424) with a unique and original bicyclic skeleton. 22b showed an orally potent analgesic in the acetic acid-induced writhing test and formalin test in ddY mice without sedation. Moreover, 22b did not exhibit mu opioid receptor agonist activity.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bmc.2020.115714DOI Listing

Publication Analysis

Top Keywords

orally potent
8
potent analgesic
8
opioid receptor
8
receptor agonist
8
agonist activity
8
discovery ds34942424
4
ds34942424 orally
4
analgesic opioid
4
activity identified
4
identified 22b
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!